Merck & Co signs $220M macrocyclic peptide deal fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.
Merck s Keytruda again bags industry-first cervical cancer nod—with limitation fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.
EconoTimes is a fast growing non-partisan source of news and intelligence on global economy and financial markets, providing timely, relevant, and critical insights for market professionals and those who want to make informed investment decisions.
By Will Feuer Merck said the Food and Drug Administration has accepted for priority review the company s V116 investigational pneumococcal conjugate vaccine. Merck said the FDA has set.